Llwytho...
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα(11) mutation
Loss-of-function mutations of GNA11, which encodes G-protein subunit α(11) (Gα(11)), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia type 2 (FHH2). FHH2 is characterized by hypercalcemia, inappropriately normal or raised parathyroid hormone...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | JCI Insight |
|---|---|
| Prif Awduron: | , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society for Clinical Investigation
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5846897/ https://ncbi.nlm.nih.gov/pubmed/29046478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.96540 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|